Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool |
|
The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells |
|
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack |
|
CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72 |
|
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells |
|
CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells |
|
CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling |
|
Characterization of the expression of MHC proteins in human embryonic stem cells |
|
Characterization of tumor infiltrating natural killer cell subset |
|
Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features |
|
Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion |
|
Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease |
|
Elucidating the mechanisms of influenza virus recognition by Ncr1 |
|
Enhanced recognition of human NK receptors after influenza virus infection |
|
Expression of ligands to NKp46 in benign and malignant melanocytes. |
|
The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes |
|
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy. |
|
HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins |
|
Host immune system gene targeting by a viral miRNA |
|
HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion |
|
The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity |
|
Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research |
|
Identification and Analysis of Natural Killer Cells in Murine Nasal Passages |
|
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma |
|
Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity |
|
Imunološki mehanizmi nastanka upale viscelarnog masnog tkiva u debljini kao podloge razvoja šećerne bolesti tipa 2 i njezinih kliničkih komplikacija |
|
Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection. |
|
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions |
|
Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface |
|
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity |
|
Intercellular transfer of carcinoembryonic antigen from tumor cells to NK cells |
|
Killing of avian and Swine influenza virus by natural killer cells |
|
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. |
|
Manipulation of NK cytotoxicity by the IAP family member Livin |
|
The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients |
|
MHC class I-independent recognition of NK-activating receptor KIR2DS4 |
|
MicroRNA editing facilitates immune elimination of HCMV infected cells |
|
MiRNA-mediated control of HLA-G expression and function |
|
Molecular mechanisms of human herpes viruses inferring with host immune surveillance |
|
The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk |
|
NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation. |
|
Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity |
|
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors |
|
NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus |
|
The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium |
|
Obesity - a public health problem and medical challenge proceedings of the Scientific Symposium held on 8 May 2014 in Rijeka |
|
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions |
|
Pregnancy-specific glycoprotein expression in normal gastrointestinal tract and in tumors detected with novel monoclonal antibodies |
|
Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading |
|
Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44. |
|
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB. |
|
The role of microRNAs in the control of innate immune response in cancer |
|
The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetes |
|
A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain |
|
Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin |
|
Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes. |
|
Tumor and viral recognition by natural killer cells receptors |
|
The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors |
|